Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Comparing ARR Versus Suppressed PRA as Screening Tests for Primary Aldosteronism

Comparing ARR Versus Suppressed PRA as Screening Tests for Primary Aldosteronism

Authors: Marcelli M, Bi C, Funder JW, McPhaul MJ

Citation: Hypertension. 2024 Jul 23. doi: 10.1161/HYPERTENSIONAHA.124.22884. Online ahead of print.

Specialties: Cardiology, Endocrinology, Cardiovascular disease

Download key summary

Related content

Conference Presentation
The diagnosis of primary aldosteronism: testing 2 screening approaches in a large reference laboratory population
Conference Presentation
Positivity Rates of Screening Criteria for Primary Aldosteronism: A Cohort Comparison Study
On-Demand Webinar
Early Identification of Type 2 Diabetes Risk for the Primary Care Setting
On-Demand Webinar
Cardiovascular Clinical Conversations: Inflammatory Markers for Defining Cardiovascular Risk
Test FAQ
CardioIQ® Insulin Resistance Panel with Score
On-Demand Webinar
Combating A Silent Killer: An Evidence-Based Update on the Treatment of Hypertension
On-Demand Webinar
The Continuum of Kidney Disease Care: From Identification to referral
Test FAQ
Apolipoprotein L1 (APOL1) Renal Risk Variant Genotyping

Related content

Audio Podcast
Unpacking Primary Aldosteronism: New Insights and Advances in Diagnosis
FAQ
Primary Aldosteronism (PA)
Audio Podcast
Instant Insight: Kidney Profile and Cystatin C

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.